Kırşehir Ahi Evran University Faculty of Health Sciences
Kırşehir, Centrum, 40100, Turkey (Türkiye)
NCT Number: NCT04739488
The most common symptom of chronic obstructive pulmonary disease (COPD) is shortness of breath and causes a decrease in the patient's quality of life. The best way to relieve shortness of breath is inhaler therapy. However, it is known that patients frequently apply this treatment incorrectly. The aim of this study is to determine the effects of breathing exercises and inhaler training for COPD patients on the severity of dyspnea and life quality.
For this, two patient groups with a total of 67 people were included in the study. While one group was trained on inhaler drug use, the other group was taught breathing exercises in addition to the inhaler drug use training. Patients were asked to continue the practices they learned regularly for 4 weeks. At the end of the study, it was observed that shortness of breath decreased and the quality of life increased in both patient groups.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Kırşehir, Centrum, 40100, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This training was given to both intervention groups. How the patients used their inhaler medication was evaluated. The steps to use the correct inhaler medication were taught sequentially. It was applied with the patient. At the end of the training, brochures prepared by the researchers were given to the patients.
This training was given only to the group that received breathing exercise and inhaler training.
Pursed lips breathing exercises were taught to the patients. Patients were asked to continue their breathing exercise for 10 minutes before using their inhaler medication.
Thus, it was evaluated whether breathing exercises performed before using inhaler drugs provided benefit on drug effectiveness.
Time frame: It was administered to patients in both groups when they were first included in the study.
Consisted of 19 questions including sociodemographic and disease features of the patients
Time frame: It was administered to patients in breathing ezercises and inhaler training group when they were first enrolled in the study.
Consisted of 18 items including the steps of breathing exercises and inhaler utilization to be applied to breathing exercises and inhaler group.
Time frame: It was administered to patients in inhaler training group when they were first enrolled in the study.
Consisted of 10 items including only the skill of applying inhaler to be applied to the both group.
Correct steps were evaluated as 1 point and wrong steps as 0 points. It was administered to patients when they were first enrolled in the study and when they came for control four weeks later.
Time frame: It was administered to patients in both groups when they were first enrolled in the study.
The scale developed by Jones et al. (2009) is used to measure the health status of individuals with COPD.
Time frame: It was administered to patients in both groups when they were first enrolled in the study.
It is a quality of life questionnaire specific to patients with COPD developed by Jones and Forde (2008).
Time frame: It was administered to patients in both groups when they were first enrolled in the study.
It was developed by the British Medical Research Council in order to provide information about the degree of dyspnea experienced by the patient based on the patient's activity and the patient's perception of the disease. As it is a one-dimensional scale Cronbach's α coefficient could not be calculated.
Time frame: It was administered to patients in both groups when they came for control four weeks later.
The scale developed by Jones et al. (2009) is used to measure the health status of individuals with COPD.
Time frame: It was administered to patients in breathing ezercises and inhaler training group when they came for control four weeks later.
Consisted of 18 items including the steps of breathing exercises and inhaler utilization to be applied to breathing exercises and inhaler group.
Time frame: It was administered to patients in inhaler training group when they came for control four weeks later.
Consisted of 10 items including only the skill of applying inhaler to be applied to the both group.
Correct steps were evaluated as 1 point and wrong steps as 0 points. It was administered to patients when they were first enrolled in the study and when they came for control four weeks later.
Time frame: It was administered to patients in both groups when they came for control four weeks later.
It is a quality of life questionnaire specific to patients with COPD developed by Jones and Forde (2008).
Time frame: It was administered to patients in both groups when they came for control four weeks later.
It was developed by the British Medical Research Council in order to provide information about the degree of dyspnea experienced by the patient based on the patient's activity and the patient's perception of the disease. As it is a one-dimensional scale Cronbach's α coefficient could not be calculated.
Kirsehir Ahi Evran Universitesi
Other
The Effects of Breathing Exercises and Inhaler Training for Chronic Obstructive Pulmonary Disease Patients on the Severity of Dyspnea and Life Quality
Acronym: COPD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03096509
Asthma, Breathlessness
Portsmouth, United Kingdom
View Trial DetailsNCT03672994
Asthma, Breathlessness
Leicester, Leicestershire, United Kingdom
View Trial DetailsNCT02622412
Breathlessness, COPD
Munich, Bavaria, Germany
View Trial DetailsNCT06473701
Breathlessness, COPD
Vejle, Region Syddanmark, Denmark
View Trial Details